By Simeon Bennett Jan. 6 (Bloomberg) — Antidepressants such as those made by GlaxoSmithKline Plc may be no better than dummy pills for people with mild or moderate depression, according to a study that suggests 70 percent of patients wouldn’t benefit from the drugs.
Find support
Communicate
